Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/vn382p/patient ) has announced the addition of the "Patient Self-Monitoring: Devices, Markets, Players and Prospects" report to their offering.
The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings.
The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context.
Highlights
- Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities
- Examines next-generation monitor technologies, design issues and evolving market factors
- Provides forecasts and market data for self-monitoring products to 2018
- Assesses the impact and influence of self-monitoring enhancements on the healthcare management market
- Profiles self-monitoring market participants, their technology, product development activity, and business strategies
Key Topics Covered
Disease Management Market Dynamics
- Patient Monitoring Overview
- Key Factors in Patient Compliance
- Market Drivers
- Shifting Patient Demographics
- Industry Alignment and Competitive Landscape
Self-Monitoring Technology Strategies
- Needle-Stick Tests
- Self-Collected / Mail-in Tests
- Combination Meters
- Continuous Monitors
- Future Developments
- Noninvasive Monitors
- Signal Processing Advances
Monitor Product Design & Patient Issues
- Reliability
- Measurement Frequency
- Patient/User Interface
- Measurement Electronics
- Calibration
- Accuracy/Precision
- Sensitivity
- Sensor Technology
Self-Monitoring Therapeutic Segments
- Atherosclerosis/Heart Disease (Cholesterol)
- Diabetes (Glucose)
- Heart Valve Replacement/Thrombosis
- Hypertension (Blood Pressure)
Self-Monitoring Product Segment Analysis
- Cholesterol Monitors
- Coagulation Monitoring
- Glucose Monitors
- Traditional Meters
- Continuous Monitors
- Noninvasive Glucose Monitors
- Combination Monitors
- Hypertension
- Potential/Emerging Self-Monitoring Segments
Market Factors
- Clinical Trial Issues
- Regulations and Guidance
- Managed care/Reimbursement
- Patient Compliance
- Sourcing/Private Labeling
Patient Self-Monitoring - Company Profile
For more information visit http://www.researchandmarkets.com/research/vn382p/patient
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics
